Key result
Higher visit-to-visit systolic (β = -0.06) and diastolic (β = -0.08) blood pressure variability independently predicted increased global cognitive decline over nearly 20 years.
Why the study?
Hypertension-related risk research for Alzheimer's disease has focused on blood pressure levels, despite evidence that blood pressure variability over time may predict poorer cardiovascular, neuropathological, and neurocognitive outcomes.
Does high visit-to-visit blood pressure variability predict global cognitive decline in a multi-ethnic cohort?
Cohort (n=1,314)
Yes
Does high visit-to-visit blood pressure variability predict global cognitive decline in a multi-ethnic cohort?
Mean Difference: -0.06 (95% CI -0.12–-0.0001)
Higher visit-to-visit systolic and diastolic blood pressure variability is an independent risk factor for cognitive decline, highlighting the potential importance of consistent blood pressure control for neurocognitive health.
Background Research of hypertension‐related risk factors for Alzheimer's disease has typically focused on blood pressure (BP) levels, despite evidence that high blood pressure variability (BPV) over time may predict poorer cardiovascular, neuropathological, and neurocognitive outcomes. We evaluated associations between BPV and cognitive function in the Multi‐Ethnic Study of Atherosclerosis (MESA). Methods Multivariable linear and logistic regression analyses of BP data across six examinations were used to determine associations that BPV (average real variability [ARV], variability independent of the mean [VIM]) and group‐based latent BP trajectories have with cognitive function, decline, and impairment, measured by the Cognitive Abilities Screening Instrument (CASI), Digit Symbol Coding (DSC), and Digit Span tests. Results Participants ( N = 1314; mean baseline age = 57) were 50% female, and 48% White. Higher systolic ( β = −0.06, 95% confidence interval [CI]: −0.12, −0.0001) and diastolic ( β = −0.08, 95% CI: −0.14, −0.02) ARV predicted increased global cognitive decline after covariate adjustment. Stronger relationships between BPV and global cognition were in older, White and Black participants, apolipoprotein E ( APOE ) ε4 non‐carriers, male participants, and non‐antihypertensive medication users. Conclusion Results suggest that higher systolic and diastolic BPV is an independent risk factor for cognitive dysfunction and decline in this multi‐ethnic cohort. This relationship differs across demographic and clinical characteristics.
No takes yet. Share an insight, caveat, or question.
Daniel et al. (2022) conducted a cohort in Cognitive decline (n=1,314). High visit-to-visit blood pressure variability vs. Low visit-to-visit blood pressure variability was evaluated on Global cognitive decline (change in CASI score) (β = -0.06, 95% CI -0.12, -0.0001). Higher visit-to-visit systolic (β = -0.06) and diastolic (β = -0.08) blood pressure variability independently predicted increased global cognitive decline over nearly 20 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: